Evidence map›Paper›PMID 40936099›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

CLAE: A High-Fidelity Nanopore Sequencing Strategy for Read-Level Viral Variant Detection and Environmental RNA Virus Discovery.

Hannah Yu, Sarah Golconda, Ga-Eun Lee, Dantong Xue, Guillermo Domínguez-Huerta, James M Wainaina, Benjamin Bolduc, Shashanka Murthy, Shihyoung Kim, Seth Faith and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Testicular mRNA-LNP Delivery: A Novel Therapy for Genetic Spermatogenic Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hannah YuCenter for Retrovirus Research, The Ohio State University, Columbus, OH, 43210, USA.
Sarah GolcondaCenter for Retrovirus Research, The Ohio State University, Columbus, OH, 43210, USA.ORCID https://orcid.org/0000-0001-6398-7285
Ga-Eun LeeCenter for Retrovirus Research, The Ohio State University, Columbus, OH, 43210, USA.
Dantong XueTranslational Data Analytics Institute, The Ohio State University, Columbus, OH, 43210, USA.
Guillermo Domínguez-HuertaCenter of Microbiome Science, The Ohio State University, Columbus, OH, 43210, USA.
James M WainainaCenter of Microbiome Science, The Ohio State University, Columbus, OH, 43210, USA.
Benjamin BolducCenter of Microbiome Science, The Ohio State University, Columbus, OH, 43210, USA.
Shashanka MurthyInfectious Diseases Institute, The Ohio State University, Columbus, OH, 43210, USA.
Shihyoung KimCenter for Retrovirus Research, The Ohio State University, Columbus, OH, 43210, USA.
Seth FaithInfectious Diseases Institute, The Ohio State University, Columbus, OH, 43210, USA.
Shan-Lu LiuCenter for Retrovirus Research, The Ohio State University, Columbus, OH, 43210, USA.
Jiyoung LeeInfectious Diseases Institute, The Ohio State University, Columbus, OH, 43210, USA.
Michael OglesbeeDepartment of Veterinary Biosciences, The Ohio State University, Columbus, OH, 43210, USA.
Matthew B SullivanInfectious Diseases Institute, The Ohio State University, Columbus, OH, 43210, USA.
Sanggu KimCenter for Retrovirus Research, The Ohio State University, Columbus, OH, 43210, USA.ORCID https://orcid.org/0000-0003-1228-6168

Funding

On-site, high-fidelity target sequencing and absolute quantitation for HIV-1 surveillanceR01HG010318 · NHGRI · OHIO STATE UNIVERSITY · PI KIM, SANGGU · 2018 to 2021
$2.9M
High-accuracy, long-range sequencing for HIV-1 genotypingR21HG010108 · NHGRI · OHIO STATE UNIVERSITY · PI KIM, SANGGU · 2018 to 2020
$624k
NHGRI NIH HHS R01 HG010318NHGRI NIH HHS R21 HG010108NIH HHS R01HG010318NIH HHS R21HG010108U.S. Department of Energy DE-SC0020173
6 · The paper itself

Abstract

High-fidelity (HF) long-read sequencing enables accurate profiling of microorganisms and pathogens at single-molecule resolution. However, current Oxford Nanopore Technologies (ONT)-a revolutionary platform offering real-time, portable sequencing at relatively low instrumental cost-suffer from severe read-length bias, limited accuracy (often <Q20), and low throughput. Here, Circular- and Linear-Amplicon-Mediated Error Correction (CLAE) is introduced, a biochemical and computational approach that addresses these limitations by integrating hairpin ligation, pre-circling, single-stranded DNA linearization, and targeted nickase-based debranching. CLAE significantly enhances rolling-circle amplification (RCA) efficiency for long DNA templates, markedly improving Nanopore sequencing yield and accuracy. CLAE achieves Q30-level accuracy in up to 27% of RCA reads, throughput exceeding 800 Mb per 100 pores, and an N50 of ≈15 Kb (bacterial genome). Moreover, its bidirectional subreads and high throughput substantially boost accuracy without compromising read length. CLAE is validated by resolving SARS-CoV-2 quasi-species from community wastewater and recovering novel, full-length RNA virus genomes from marine samples. CLAE enables precise variant detection in complex samples and corrects short-read misassemblies, significantly broadening ONT's utility in metaviromics, epidemiology, and environmental surveillance. Thus, CLAE establishes a versatile, field-compatible platform for high-fidelity viral genome sequencing in targeted and agnostic contexts.

Indexed as

Nanopore SequencingRNA VirusesHigh-Throughput Nucleotide SequencingNanoporesSARS-CoV-2high‐fidelity long‐readsmetaviromicsnanopore sequencingocean viromeRNA virusesrolling circle amplificationSARS‐CoV‐2

Identifiers

PMID40936099
PMCPMC12667459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.